Related Experiment Videos
Novel antibiotics: macrocyclic peptides designed to trap Holliday junctions
Megan L Bolla1, Enrique V Azevedo, Jason M Smith
1Department of Chemistry, Molecular Biology Institute, and Center for Applied and Experimental Genomics, 5500 Campanile Drive, 208 CSL, San Diego State University, San Diego, California 92182-1030, USA.
Organic Letters
|January 17, 2003
Summary
Researchers synthesized novel macrocyclic peptides to trap bacterial Holliday junctions, inhibiting growth. This work advances the development of a new class of antibiotics targeting bacterial DNA repair mechanisms.
Area of Science:
- Medicinal Chemistry
- Molecular Biology
- Antibiotic Discovery
Background:
- Holliday junctions are crucial for bacterial DNA repair.
- Targeting Holliday junctions offers a potential antibiotic strategy.
- Existing antibiotics have limitations, necessitating new approaches.
Purpose of the Study:
- To synthesize novel macrocyclic peptides.
- To design peptides that trap bacterial Holliday junctions.
- To evaluate their potential as antibiotics.
Main Methods:
- Synthesis of eight macrocyclic peptides from three monomers.
- Utilizing a combinatorial-like strategy.
- Designing macrocycles from linear dimerized hexapeptides.
Main Results:
- Successful synthesis of eight macrocyclic peptides.
- Demonstrated ability of macrocycles to bind to C-2 symmetrical Holliday junctions.
- Elucidation of monomer roles in junction accumulation and antibiotic activity.
Conclusions:
- Macrocyclic peptides are effective in trapping bacterial Holliday junctions.
- These compounds represent a promising new class of antibiotics.
- Further development could lead to novel antibacterial therapies.